72.8
Citius Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
44.6
FY23:
34.4
FY24:
14.2
FY25:
27.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
69.6
FY22:
69.4
FY23:
69.2
FY24:
102
FY25:
103
Total assets
Change from FY21 to FY25
millions USD
FY21:
142
FY22:
114
FY23:
104
FY24:
117
FY25:
131
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.98
FY22:
4.53
FY23:
5.78
FY24:
35.8
FY25:
44.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.66
FY22:
6.04
FY23:
6.40
FY24:
6.74
FY25:
8.50
(positive)
Change from FY21 to FY25
millions USD
FY21:
132
FY22:
103
FY23:
90.8
FY24:
70.1
FY25:
67.6
Total liabilities & equity
Change from FY21 to FY23
millions USD
FY21:
142
FY22:
113
FY23:
103
FY24:
–
FY25:
–
All amounts in millions USD